Oncolytics Biotech

Yahoo Finance • 13 days ago

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology

VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financi... Full story

Yahoo Finance • last month

THE INFRASTRUCTURE REALIGNMENT: 5 Stocks Positioning for the 2026 Supply Imperative

VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Equity InsiderMarket Intelligence Brief — WHAT’S HAPPENING: Gold above $5,000 per ounce[1]. The White House mobilized $12 billion for critical mineral stockpiling[2]. The F... Full story

Yahoo Finance • 2 months ago

Oncolytics surges on Fast Track status for pelareorep in colorectal cancer

[Colon cancer. Cancer attacking cell. Colon disease concept. 3d illustration] Mohammed Haneefa Nizamudeen * Oncolytics Biotech (ONCY [https://seekingalpha.com/symbol/ONCY]) is up ~15% in premarket trading Wednesday after announcing that... Full story

Yahoo Finance • 3 months ago

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faster regulatory pathways... Full story

Yahoo Finance • 4 months ago

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality

VANCOUVER, British Columbia, Dec. 06, 2025 (GLOBE NEWSWIRE) -- USANewsGroup.comMarket Intelligence Brief – The market is efficient... until it isn't. While the S&P 500 grinds higher on momentum, entire subsectors have been left behind, c... Full story

Yahoo Finance • 4 months ago

UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality

VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- USANewsGroup.comMarket Intelligence Brief – Efficient Market Theory often fails in the small-cap sector. In this space, price discovery is slow. It lags behind the news. This... Full story

Yahoo Finance • 4 months ago

The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality

VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- USANewsGroup.comMarket Intelligence Brief – Efficient Market Theory often fails in the small-cap sector. In this space, price discovery is slow. It lags behind the news. This... Full story

Yahoo Finance • 4 months ago

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B

PALM BEACH, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The precision oncology sector is experiencing unprecedented transformation as biomarker-driven therapies and platform immunotherapies reshape treatment... Full story

Yahoo Finance • 5 months ago

Oncolytics Biotech entered into $50M at-the-market sales agreement with BTIG

Oncolytics Biotech (NASDAQ:ONCY [https://seekingalpha.com/symbol/ONCY]) has established a new at-the-market equity financing agreement with BTIG, LLC. As disclosed in a Securities and Exchange Commission (SEC) filing [https://seekingalpha.... Full story

Yahoo Finance • 7 months ago

Large-cap biotech is a sector to watch for investors: Analysts

Wall Street is looking for new ways to park cash in healthcare names, and large-cap biotechs have begun to gain steam. This asset class differs from traditional large-cap pharmaceutical companies — typically with a $200 billion market cap... Full story

Yahoo Finance • 8 months ago

Oncolytics Biotech announces voting results from annual meeting

SAN DIEGO - Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), whose stock has delivered an impressive 56% return year-to-date according to InvestingPro data, reported Monday that shareholders elected all eight director nominees at its Annua... Full story

Yahoo Finance • 8 months ago

Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep

Key opinion leader event and pancreatic cancer clinical data validate decision to engage with regulators on plans for a registration-enabling study New members of the management team bring expertise in progressing clinical programs and ex... Full story

Yahoo Finance • 8 months ago

Onc stock hits 52-week high at 309.25 USD

Onc stock reached a significant milestone, hitting a 52-week high of 309.25 USD. The $36.11 billion market cap company’s achievement reflects a robust performance over the past year, during which BeOne Medicines AG DRC, the company behind... Full story

Yahoo Finance • 8 months ago

Oncolytics Biotech regains compliance with Nasdaq listing requirements

SAN DIEGO/CALGARY - Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), a $34.64 billion market cap company, has regained compliance with Nasdaq’s minimum bid price requirement, according to a formal notice received Tuesday from the exchange’... Full story

Yahoo Finance • 9 months ago

Oncolytics Biotech reports positive biomarker data for pelareorep

SAN DIEGO/CALGARY - Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC), a clinical-stage biotechnology company with a market capitalization of approximately $108 million, announced Wednesday that integrated biomarker analyses from multiple cl... Full story

Yahoo Finance • 9 months ago

Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

PALM BEACH, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions... Full story

Yahoo Finance • 9 months ago

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

SAN DIEGO and CALGARY, Alberta, June 30, 2025 /CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Andrew Aromando as C... Full story

Yahoo Finance • 10 months ago

Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences

PALM BEACH, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organizati... Full story

Yahoo Finance • last year

Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus

PALM BEACH, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The demand for effective pancreatic cancer treatments is and has been undeniably high. The growing number of diagnoses, with the aggressive nature of th... Full story

Yahoo Finance • 3 years ago

Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial

Adaptive clinical trial designed to accelerate registration pathways for pancreatic cancer therapies and expected to reduce cost of a Phase 3 study for pelareorep by ~50% compared to a traditional trial If successful, new clinical study e... Full story